ArticleExperimental hematology2016

Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study.

Jie Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.